Kronos Bio Stock (NASDAQ: KRON) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 50.00 / 163.10K |
Day Range | - - - |
52 Wk Range | 0.69 - 1.60 |
Market Cap | $60.90M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 1.66% |
Days to Cover | 6.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kronos Bio (NASDAQ:KRON) through any online brokerage.
Other companies in Kronos Bio’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Serina Therapeutics (AMEX:SER), Cellectar Biosciences (NASDAQ:CLRB), Intensity Therapeutics (NASDAQ:INTS) and Connect Biopharma Hldgs (NASDAQ:CNTB).
Kronos Bio has a consensus price target of $8.56.
The stock price for Kronos Bio (NASDAQ: KRON) is $1.01 last updated September 20, 2024 at 5:42 PM EDT.
There are no upcoming dividends for Kronos Bio.
Kronos Bio’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Kronos Bio.
Kronos Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.